John Lieb, II

A Phase 2a, Multi -Center, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of a Single Dose ofRABI-767 Administered by Endoscopic Ultrasound-Guided Peripancreatic Injection Plus Standard-of-Care Versus Standard-of-Care Only in Participants with Predicted Severe Acute Pancreatitis